European shares climb on vaccine hopes, mixed earnings

EUROPEAN shares rebounded on Wednesday from losses in the previous session, bolstered by positive updates on a potential Covid-19 vaccine, while investors weighed a mixed bag of quarterly reports at the start of the earnings season.

The pan-European STOXX 600 rose 0.8% by 0720 GMT, with travel & leisure and miners leading gains.

Market sentiment got a boost after US biotech firm Moderna Inc’s experimental vaccine for Covid-19 showed it was safe and provoked immune responses in an ongoing early-stage study.

Hopes were high among investors heading into a EU summit later this week that leaders will agree on a recovery fund of €750 bil (RM3.64 tril) for pandemic-hammered economies.

Swedish telecom operator Tele2 AB jumped 4.1% as it reaffirmed its 2020 earnings outlook and plans for an extra shareholder payout.

Semiconductor equipment maker ASML Holding NV slipped 1.3% despite forecasting overall growth for 2020.

British fashion brand Burberry dropped 5.1% as it warned second-quarter revenue will remain impacted by the pandemic. – July 15, Reuters

Subscribe and get top news delivered to your Inbox everyday for FREE